Ying Chen

Title: Ying Chen - Innovator in Viral Infection Treatment

Introduction

Ying Chen is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of medicine, particularly in the treatment of viral infections. His innovative work has led to the development of a unique pharmaceutical composition that utilizes PIM1 inhibitors.

Latest Patents

Ying Chen holds a patent for "PIM1 inhibitors for use in treatment of viral infection and pharmaceutical compositions thereof." This patent describes a PIM-1 proto-oncogene, serine/threonine kinase (PIM1) inhibitor that is effective in treating viral infections. The method involves administering an effective antiviral amount of a PIM1 inhibitor to a human afflicted with a viral infection. Additionally, the patent outlines a pharmaceutical composition for treating viral infections that includes a PIM1 inhibitor and a pharmaceutically acceptable excipient. Ying Chen has 1 patent to his name.

Career Highlights

Ying Chen is affiliated with the City University of Hong Kong, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential impact on treating viral infections, showcasing his dedication to advancing healthcare.

Collaborations

Ying Chen has collaborated with notable colleagues, including Ming-Liang He and Fanghang Zhou. These partnerships have contributed to the advancement of research and development in his field.

Conclusion

Ying Chen's contributions to the treatment of viral infections through his innovative use of PIM1 inhibitors highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in pharmaceutical compositions and treatment methods.